Skip to main content
Premium Trial:

Request an Annual Quote

Applied Markets News: Life Tech, Copan Flock Pact; Applied Genetics' Johne's Disease Partnership


Life Technologies said this week that it has signed an agreement with Copan Flock to provide an integrated, end-to-end system for DNA forensics.

Terms of the agreement call for Life Tech to globally distribute Copan's sample-collection systems for forensic applications. Copan's Nucleic-Card DNA collection system is a chemically treated sample collection matrix that lyses cells and preserves DNA spotted onto a paper substrate, and can help facilitate rapid and direct PCR amplification using Life Tech's STR kits.

Adding Copan's products will enable Life Tech to offer forensic and paternity customers an integrated solution across the entire forensics workflow, Life Tech added.

"By enabling our customers to collect DNA samples directly onto the paper or swab, which has been designed to optimally release a maximum amount of DNA, they will see an improvement in overall efficiency and success," John Gerace, head of applied sciences for Life Technologies, said in a statement.

Further terms of the agreement were not disclosed.

GeneThera said this week that its Monterrey, Mexico-based Applied Genetics subsidiary has signed a research and test-validation agreement with Universidad National Autonoma de Mexico.

As part of the agreement the partners will validate GeneThera's Johne's disease HerdCheck Field Collection System molecular assay in Mexico. Johne's disease is an incurable disease of dairy cows, sheep, and goats caused by a bacterium called Mycobacterium paratuberculosis sub. Avium.

GeneThera is a molecular biotech firm based in Westminster, Colo. Its HerdCheck product is a proprietary molecular diagnostic system based on high-throughput robotics and real-time PCR.

"It is extremely critical that we can diagnose Johne's disease in Mexico using the most advanced technology available," Gilberto Chaves Griz, professor of veterinary pathology at UNAM and director of the Johne's Disease Center, said in a statement. "It is our firm intention to establish a national testing program for Johne's disease in Mexico with the help of Applied Genetics and GeneThera's state-of-the-art technology."

The Scan

Not as High as Hoped

The Associated Press says initial results from a trial of CureVac's SARS-CoV-2 vaccine suggests low effectiveness in preventing COVID-19.

Finding Freshwater DNA

A new research project plans to use eDNA sampling to analyze freshwater rivers across the world, the Guardian reports.

Rise in Payments

Kaiser Health News investigates the rise of payments made by medical device companies to surgeons that could be in violation of anti-kickback laws.

Nature Papers Present Ginkgo Biloba Genome Assembly, Collection of Polygenic Indexes, More

In Nature this week: a nearly complete Ginkgo biloba genome assembly, polygenic indexes for dozens of phenotypes, and more.